NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 72 filers reported holding NOVOCURE LTD in Q1 2017. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 415,479 | $13,910,000 | 19.11% |
| HARTLINE INVESTMENT CORP/ | 405,066 | $13,562,000 | 4.13% |
| APIS CAPITAL ADVISORS, LLC | 81,100 | $2,715,000 | 3.64% |
| Darsana Capital Partners LP | 2,150,000 | $71,982,000 | 3.01% |
| Rhenman & Partners Asset Management AB | 545,000 | $18,247,000 | 2.09% |
| Taylor Frigon Capital Management LLC | 43,686 | $1,463,000 | 1.29% |
| COURAGE CAPITAL MANAGEMENT LLC | 40,000 | $1,339,000 | 1.04% |
| Tygh Capital Management, Inc. | 127,973 | $4,285,000 | 0.90% |
| Granite Investment Partners, LLC | 332,667 | $11,138,000 | 0.81% |
| Steinberg Global Asset Management | 135,394 | $4,533,000 | 0.78% |